|
DIGITAL ANGEL TO DEVELOP NEW SUBMARINE BEACON FOR ROYAL
NETHERLANDS NAVY
$150,000 Initial Order; Additional Equipment Contract
Expected
SO. ST. PAUL, MN. (December 8, 2006) – Digital Angel
Corporation (AMEX: DOC) announced today that the SARBE Division of its
London-based subsidiary, Signature Industries, has signed a new contract
to develop and supply a new crew escape system for submarines for the
Royal Netherlands Navy. The initial development contract to SARBE is for
$150,000 and SARBE expects additional orders for equipment
purchases.
“SARBE will develop and supply an automatically
activated and deployed emergency radio which will alert rescue authorities
and pinpoint a stricken submarine submerged or on the surface,” said David
Cairnie, CEO of Signature Industries. “This is a prestigious contract and
we’re honored SARBE has been selected to create this new product.”
SARBE, a world leader in search and rescue radios, RFD Beaufort,
the leader in Submarine Escape Equipment and Weir Strachan and Henshaw, a
design authority for submarine launch systems, have partnered in a joint
venture to develop the equipment. The venture, Integrated Submarine Escape
Capability (ISEC), will collaborate to effectively meet personnel escape
requirements from submerged vessels or during surface abandonment
situations.
The Royal Netherlands Navy has selected the ISEC
System, which triggers the launch of a 35-man life raft either on the
surface or at deep-sea levels. Once inflated, the new SARBE beacon is
automatically activated and sends emergency Cospas-Sarsat 406 MHz
transmissions for up to 10 days.
The Walrus class vessels will be
the first submarines to be fitted with the equipment. SARBE is also
pursuing opportunities to supply beacons to Scorpene submarines that have
been ordered by the Navies of Malaysia, India and Chile.
About Digital Angel Corporation
Digital Angel
Corporation develops and deploys sensor and communications technologies
that enable rapid and accurate identification, location tracking, and
condition monitoring of high-value assets. Applications for the Company’s
products include identification and monitoring of humans, pets, fish,
poultry and livestock through its patented implantable microchips;
location tracking and message monitoring of vehicles and aircraft in
remote locations through systems that integrate GPS and geosynchronous
satellite communications; and monitoring of asset conditions such as
temperature and movement, through advanced miniature
sensors.
Digital Angel Corporation is majority-owned by Applied
Digital Inc. (Nasdaq:ADSX). For more information about Digital Angel,
please visit http://www.digitalangelcorp.com/.
The statements in this press release that are not strictly
historical, are "forward-looking" statements within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934 and are intended to be covered by the safe harbors
created by these sections. The forward-looking statements are subject to
risks and uncertainties and the actual results that the Company achieves
may differ materially from these forward-looking statements due to such
risks and uncertainties, including, but not limited to, that Applied
Digital Inc. owns 55.4% of the Company’s common stock, that new accounting
pronouncements regarding expensing of share based compensation may impact
the Company’s future results of operations, the Company may continue to
incur net losses, infringement by third parties on the Company’s
intellectual property or development of substantially equivalent
proprietary technology by the Company’s competitors could negatively
impact the Company’s business, domestic and foreign government regulation
and other factors could impair the Company’s ability to develop and sell
its products in certain markets, the Company relies on sales to government
contractors for its animal identification and search and rescue beacon
products, and any decline in the demand by these customers for such
products could negatively affect the Company’s business, the Company
depends on a single production arrangement for its patented
syringe-injectable microchips, and the loss of or any significant
reduction in the production could have an adverse effect on the Company’s
business, technological change could cause the Company’s products to
become obsolete, the loss of one of the Company’s principal customers
could negatively impact the Company’s net revenue, the Company’s earnings
will decline if the Company writes off goodwill and other intangible
assets, options and warrants outstanding and available for issuance may
adversely affect the market price of the Company’s common stock, currency
exchange rate fluctuations could have an adverse effect on the Company’s
sales and financial results, the Company depends on a small team of senior
management. A detailed statement of risks and uncertainties is contained
in the Company’s reports to the Securities and Exchange Commission,
including in particular the Company’s Form 10-K for the fiscal year ended
December 31, 2005. Investors and stockholders are urged to read this
document carefully. The Company can offer no assurances that any
projections, assumptions or forecasts made or discussed in this release
will be met, and investors should understand the risks of investing solely
due to such projections. The Company undertakes no obligation to revise
any forward-looking statements in order to reflect events or circumstances
that may arise after the date of this press release.
|